Lv6
1620 积分 2023-05-02 加入
Dissection of Immunotherapeutic Predictive versus Prognostic Transcriptional Programs Identifies SLC22A5-Centric Carnitine Metabolism-Driven Resistance to Anti-PD-(L)1 Treatment in Advanced Non-Small Cell Lung Cancer
10天前
已完结
Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial
1个月前
已完结
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial
1个月前
已完结
High-dose ascorbic acid selectively induces pyroptosis in LKB1-deficient lung cancer and sensitizes immunotherapy
1个月前
已完结
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
1个月前
已完结
Immune-Related Adverse Events and Efficacy—The More It Hurts, the Better It Works?
1个月前
已完结
HMGB1 in exosomes derived from gastric cancer cells induces M2‐like macrophage polarization by inhibiting the NF‐κB signaling pathway
2个月前
已完结
KRAS-G12 inhibitors in lung cancer therapy: unveiling the toxicity profile through a pharmacovigilance study
2个月前
已完结
Comprehensive analysis of ADGRE5 gene in human tumors: Clinical relevance, prognostic implications, and potential for personalized immunotherapy
2个月前
已完结
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
